News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Luis Lara-Mejía: Radiotherapy in 1st Line Metastatic NSCLC
Luis Lara-Mejía/X
May 13, 2025, 10:51

Luis Lara-Mejía: Radiotherapy in 1st Line Metastatic NSCLC

Luis Lara-Mejía, Medical Oncologist Specialized in Thoracic Neoplasms at National Institute of Cancerology, shared an article on X:

“New data from NJLCG 1902 (Phase 2):

Radiotherapy added to pembrolizumab and platinum-doublet chemo in 1L metastatic NSCLC:

  • 12-mo PFS: 44.3%,
  • median OS: 30.1 mo.
  • Grade ≥3 AEs: 65.8%;
  • Pneumonitis in 26.3% Protocol: RT (30 Gy/10 fx) started <7 days before systemic Tx.

Promising efficacy—but pneumonitis remains a concern.

Tagging para amplificar: IASLC, JTO & JTO CRR.”

Luis Lara-Mejía: Radiotherapy in 1st Line Metastatic NSCLC

Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902.

Authors: Yoko Tsukita, Rei Umezawa, Taku Nakagawa, Akira Anbai, Tomonori Makiguchi, Hisashi Tanaka, Yosuke Horii, Aya Suzuki, Ryo Morita, Hitomi Nogawa, Hiroshi Yokouchi, Nozomu Kimura, Keiichi Jingu, Akira Inoue, Hisatoshi Sugiura, Eisaku Miyauchi.

You can read the Full Article on Journal of JTO Clinical and Research Reports.

Luis Lara-Mejía: Radiotherapy in 1st Line Metastatic NSCLC

More posts featuring Luis Lara-Mejía.

Akira Anbai Akira Inoue Aya Suzuki cancer Eisaku Miyauchi Eisaku Miyauchi.Yoko Tsukita fight against cancer Global fight against cancer Hiroshi Yokouchi Hisashi Tanaka Hisatoshi Sugiura Hitomi Nogawa IASLC JTO & JTO CRR JTO Clinical and Research Reports Keiichi Jingu Luis Lara-Mejía MedOnc metastatic NSCLC National Institute of Cancerology NJLCG 1902 Nozomu Kimura NSCLC OncoDaily Oncology pembrolizumab pneumonitis radiotherapy Rei Umezawa Ryo Morita Taku Nakagawa Thoracic Neoplasms Tomonori Makiguchi Yoko Tsukita Yosuke Horii
Special Coverage
Science
May 13, 2025, 10:51
Luis Lara-Mejía: Radiotherapy in 1st Line Metastatic NSCLC
Blog
May 13, 2025, 10:42
Chinmay Jani: Grateful for an Incredible Weekend at the Next Wave Lung Forum
Blog
May 13, 2025, 10:39
Let's Fight Colorectal Cancer - National Cancer Institute of Kenya
Blog
May 13, 2025, 10:32
DIPG is one of the most aggressive, with limited treatment options - St. Baldrick's Foundation
Blog
May 13, 2025, 10:26
Goutham Sunny: Economic Crisis Affected Access to Immunotherapy in Metastatic NSCLC
Science
May 13, 2025, 10:18
Trisha Santos: Gaps in Emergency Medicaid for Undocumented Immigrants
Blog
May 13, 2025, 10:10
ECO - Registration is Open for Beyond the Glow: The Harmful Effects of Sunbeds on Public Health Conference
Blog
May 13, 2025, 10:08
Praveen Kumar Marimuthu: IMRT Not Better Than 3DCRT in RAPIDO
Blog
May 13, 2025, 10:06
Amar Kishan: Proud of Jesus Juarez and Eulanca Liu for their award-winning JCCC Fellowship Research
Blog
May 13, 2025, 10:02
Habib Nehmé Reflects on Leadership Lessons from GE and Elekta at Work Anniversary
Science
May 13, 2025, 10:00
Pavlos Msaouel: SCD induces chromatin introversion and ferroptosis in CD8+ T cells to suppress anti-tumor immunity
Blog
May 13, 2025, 09:54
Qatar Cancer Society Promotes HPV Vaccine as Cancer Prevention Tool